Once-daily dolutegravir/lamivudine fixed-dose formulations in children living with HIV: a pharmacokinetic and safety sub-study nested in the open-label, multicentre, randomised, non-inferiority D3/PENTA 21 trial
在 HIV 感染儿童中每日一次服用多替拉韦/拉米夫定固定剂量制剂:一项嵌套于开放标签、多中心、随机、非劣效性 D3/PENTA 21 试验中的药代动力学和安全性子研究
期刊:EBioMedicine
影响因子:
doi:10.1016/j.ebiom.2025.105929
Bevers, Lisanne A H; Toledo, Gabriela; Kisekka, Muzamil; Kaudha, Elizabeth; Ahimbisibwe, Grace M; Deprez, Isabelle; Arumugan, Tiyara; Variava, Ebrahim; Violari, Avy; White, Iona; Bbuye, Dickson; Nanduudu, Annet; Mulwanyi, Enoch; Amuge, Pauline; Rutebarika, Diana A; Kekitiinwa, Adeodata; Kityo, Cissy; Musoke, Philippa; Archary, Moherndran; Boles, Justine; Thomason, Margaret J; de Wildt, Saskia N; Giaquinto, Carlo; Colbers, Angela; Burger, David M; Buchanan, Ann M; Chan, Man K; Jacobs, Tom G; Turkova, Anna